Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Dec 5 2017

Full Issue

Viewpoints: Examining The Proposed $69B CVS-Aetna Merger; Is Medicare Next On GOP Chopping Block?

A selection of opinions on health care from around the country.

Los Angeles Times: CVS And Aetna Say Their Huge Merger Will Be Great For Consumers. Here's Why You Should Be Skeptical

The CEOs of drug retailer CVS and health insurer Aetna were marvelously in sync Sunday when they jointly announced their companies’ $69-billion merger deal. The deal will “dramatically further empower consumers,” Aetna’s Mark Bertolini said. It will “create a platform that is easier to use and less expensive for consumers,” according to Larry J. Merlo, president and CEO of CVS Health. They repeated these mantras to the press in a series of joint interviews. All that was missing was a clue to how, exactly, this nirvana of better, cheaper healthcare was to be reached. (Michael Hiltzik, 12/4)

Los Angeles Times: Less Choice, Higher Prices Feared In CVS' Takeover Of Health Insurer Aetna

CVS Health says that its $69-billion takeover of insurance giant Aetna will be good for consumers. That, of course, is unlikely. For the deal to benefit consumers, it would have to result in lower drug prices or lower insurance costs. If past mergers are anything to go by, this won't happen. (David Lazarus, 12/4)

Stat: Retail Health Care Lacks Personal Connections That Patients Want And Need

Retail thinking has its place in health care today because there are some services and products that people need quickly and which do not require a personal touch or someone who understands them as unique individuals. Such services might be low-level acute care (think strep throat), flu shots and immunizations, and some forms of simple chronic disease management, such as blood sugar checks or foot and eye exams for people with diabetes, especially if they are guideline driven. There’s no question that retail thinking can also create purchasing opportunities for things patients find useful, if not always essential, and perhaps do so in ways that are cost-effective or convenient for us. But retail health care is impersonal, lacks relational warmth, and isn’t what patients really want. (Timothy J. Hoff, 12/4)

The Kansas City Star: Tax Cuts Are Only The Start. Social Security And Medicare Could Be Next On The Chopping Block

Early Saturday morning, every Republican in the U.S. Senate — save one — endorsed a budget-busting tax cut that will do irreparable harm to the economy over the next decade. Their work isn’t done. A committee must hammer out differences between the House and Senate legislation, but that task now seems easy. Expect a tax bill to be signed before Christmas. As frustrating as that reality is, the worst may be yet to come. Cuts to Social Security, Medicare and Medicaid are likely to be next on the agenda. (12/4)

The Minneapolis Star Tribune: House, Senate Tax Bills Will Make America Sicker

The Senate bill’s likely effects on typical health policy concerns are substantial and devastating: 13 million people could lose health insurance due to the repeal of the ACA individual mandate, and large future cuts to Medicaid and Medicare are likely in order to compensate for the ballooning deficit. But these consequences on health insurance only scratch the surface of the legislation’s potential public health impacts. By promoting the interests of the wealthy while shortchanging investments in the social factors that promote health for all of us, the House and Senate tax bills are even more damaging to our nation’s health than repealing the ACA. (Sarah E. Gollust, 12/4)

Axios: ACA Mandate Repeal May Be Less Popular Than GOP Thinks

The tax bill that just passed the Senate eliminates the Affordable Care Act's individual mandate, and the House is likely to go along when Congress writes the final version. ... Our polls have consistently shown that the mandate is the least popular element of the ACA and in the abstract, more Americans (55%) would eliminate the mandate than keep it (42%). Yes, but: When people know how the mandate actually works, and are told what experts believe is likely to happen if it's eliminated, most Americans oppose repealing it in the tax plan. (Drew Altman, 12/5)

St. Louis Post-Dispatch: The Misunderstood Social Safety Net

The social safety net, or welfare system, consists of a handful of programs. They include Medicaid, the Supplemental Nutrition Assistance Program (better known as food stamps), housing and disability assistance programs, Temporary Assistance for Needy Families, and several others. The programs are designed to provide stopgap assistance until households are able to get back on their feet, and in order to qualify, individuals must be close to or living in poverty. (Mark R. Rank, 12/4)

The New York Times: Why A Lot Of Important Research Is Not Being Done

We have a dispiriting shortage of high-quality health research for many reasons, including the fact that it’s expensive, difficult and time-intensive. But one reason is more insidious: Sometimes groups seek to intimidate and threaten scientists, scaring them off promising work. By the time I wrote about the health effects of lead almost two years ago, few were questioning the science on this issue. But that has not always been the case. (Aaron E. Carroll, 12/4)

Miami Herald: Miami’s Bascom Palmer: Offering Eye Care In Battered Puerto Rico

Bascom Palmer Eye Institute’s clinical professionals know that every natural disaster has a unique impact on the delivery of sight-saving vision care. After Hurricane Katrina in 2006, our physician-led team spent two weeks in Louisiana and Mississippi providing eye care to residents and first responders. Within 48 hours after the 2010 earthquake, a team from Bascom Palmer arrived in Haiti with ophthalmic equipment and supplies to offer general medical aid and eye surgery. The following year, we transported the Vision Van, our mobile eye clinic, across the Pacific to serve as a base for Japanese ophthalmologists caring for victims of the deadly earthquake and tsunami. (Eduardo C. Alfonso, 12/5)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF